NDC PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NDC PHARMA
Largest movements
- Cash -€75,514
down €75,514 (-41.8%), from €180,665 to €105,151
mainly Contributions, distributions and other (-€187,648) and Receivables within one year (-€56,848)
- Receivables within one year +€56,848
up €56,848 (+51.8%), from €109,795 to €166,643
of which Trade receivables: +€32,142
- Stocks and contracts +€29,574
up €29,574 (+12.4%), from €238,413 to €267,988
- Tangible fixed assets -€14,037
down €14,037 (-6.0%), from €235,115 to €221,077
of which Land and buildings: -€10,950
- Trade debts +€25,854
up €25,854 (+34.7%), from €74,508 to €100,362
- Tax, wage and social debts -€9,710
down €9,710 (-41.6%), from €23,322 to €13,613
of which Taxes: -€5,170
- Debts after one year -€9,037
down €9,037 (-5.8%), from €156,397 to €147,360
- Gross operating margin +€61,341
up €61,341 (+16.2%), from €379,505 to €440,846
- Depreciation -€26,333
down €26,333 (-63.7%), from €41,370 to €15,037
- Staff costs +€4,799
up €4,799 (+2.2%), from €217,594 to €222,392
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €768,504 | €772,892 | +€4,388 | +0.6% |
| Fixed assets | 21/28 | €235,125 | €226,087 | -€9,037 | -3.8% |
| Tangible fixed assets | 22/27 | €235,115 | €221,077 | -€14,037 | -6.0% |
| Land and buildings | 22 | €212,270 | €201,320 | -€10,950 | -5.2% |
| Plant, machinery and equipment | 23 | €22,845 | €18,814 | -€4,031 | -17.6% |
| Furniture and vehicles | 24 | - | €944 | +€944 | |
| Financial fixed assets | 28 | €10 | €5,010 | +€5,000 | +50000.0% |
| Current assets | 29/58 | €533,379 | €546,805 | +€13,425 | +2.5% |
| Stocks and contracts in progress | 3 | €238,413 | €267,988 | +€29,574 | +12.4% |
| Stocks | 30/36 | €238,413 | €267,988 | +€29,574 | +12.4% |
| Amounts receivable within one year | 40/41 | €109,795 | €166,643 | +€56,848 | +51.8% |
| Trade receivables | 40 | €107,569 | €139,711 | +€32,142 | +29.9% |
| Other amounts receivable | 41 | €2,226 | €26,932 | +€24,706 | +1109.9% |
| Cash at bank and in hand | 54/58 | €180,665 | €105,151 | -€75,514 | -41.8% |
| Deferred charges and accrued income | 490/1 | €4,506 | €7,023 | +€2,517 | +55.9% |
| Total equity and liabilities | 10/49 | €768,504 | €772,892 | +€4,388 | +0.6% |
| Equity | 10/15 | €233,385 | €234,089 | +€704 | +0.3% |
| Contributions | 10/11 | €70,000 | €70,000 | = | 0.0% |
| Capital | 10 | €70,000 | €70,000 | = | 0.0% |
| Issued capital | 100 | €70,000 | €70,000 | = | 0.0% |
| Reserves | 13 | €163,385 | €164,089 | +€704 | +0.4% |
| Non-distributable reserves | 130/1 | €7,000 | €7,000 | = | 0.0% |
| Legal reserve | 130 | €7,000 | €7,000 | = | 0.0% |
| Distributable reserves | 133 | €156,385 | €157,089 | +€704 | +0.5% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €535,119 | €538,803 | +€3,684 | +0.7% |
| Amounts payable after more than one year | 17 | €156,397 | €147,360 | -€9,037 | -5.8% |
| Financial debts | 170/4 | €156,397 | €147,360 | -€9,037 | -5.8% |
| Amounts payable within one year | 42/48 | €378,722 | €391,443 | +€12,720 | +3.4% |
| Current portion of amounts payable after more than one year | 42 | €8,689 | €9,037 | +€347 | +4.0% |
| Trade debts | 44 | €74,508 | €100,362 | +€25,854 | +34.7% |
| Suppliers | 440/4 | €74,508 | €100,362 | +€25,854 | +34.7% |
| Advances received on contracts in progress | 46 | - | €213 | +€213 | |
| Taxes, remuneration and social security | 45 | €23,322 | €13,613 | -€9,710 | -41.6% |
| Taxes | 450/3 | €5,206 | €36 | -€5,170 | -99.3% |
| Remuneration and social security | 454/9 | €18,116 | €13,577 | -€4,539 | -25.1% |
| Other amounts payable | 47/48 | €272,202 | €268,218 | -€3,985 | -1.5% |
| Remuneration, social security and pensions | 62 | €217,594 | €222,392 | +€4,799 | +2.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €41,370 | €15,037 | -€26,333 | -63.7% |
| Other operating charges | 640/8 | €6,500 | €2,786 | -€3,714 | -57.1% |
| Gross operating margin | 9900 | €379,505 | €440,846 | +€61,341 | +16.2% |
| Operating profit (loss) | 9901 | €114,041 | €200,631 | +€86,590 | +75.9% |
| Financial income | 75/76B | €2,486 | €1,998 | -€488 | -19.6% |
| Recurring financial income | 75 | €2,486 | €1,998 | -€488 | -19.6% |
| Financial charges | 65/66B | €9,930 | €8,793 | -€1,137 | -11.4% |
| Recurring financial charges | 65 | €9,930 | €8,793 | -€1,137 | -11.4% |
| Profit (loss) for the period before taxes | 9903 | €106,597 | €193,836 | +€87,238 | +81.8% |
| Income taxes | 67/77 | €5,095 | €5,483 | +€389 | +7.6% |
| Profit (loss) for the period | 9904 | €101,503 | €188,352 | +€86,850 | +85.6% |
| Profit (loss) for the period to be appropriated | 9905 | €101,503 | €188,352 | +€86,850 | +85.6% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.